Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
44 hedge funds and large institutions have $1.11B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 9 closing their positions.
1% more capital invested
Capital invested by funds: $1.1B → $1.11B (+$10.1M)
6% less funds holding
Funds holding: 47 → 44 (-3)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$31.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$15.2M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$8.54M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.38M |
| 5 |
Morgan Stanley
New York
|
+$5.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$17.2M |
| 2 |
P8IP
Pier 88 Investment Partners
San Francisco,
California
|
-$16.6M |
| 3 |
ACM
Advent Capital Management
New York
|
-$10.4M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$9.04M |
| 5 |
FSA
Financial Sense Advisors
San Diego,
California
|
-$8.74M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FSA
51
Financial Sense Advisors
San Diego,
California
| – | -$8.74M | -76,271 | Closed |
|
|
JG
52
Jefferies Group
New York
| – | -$2.27M | -19,812 | Closed |
|
|
EDRH
53
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | -$389K | -3,400 | Closed |
|
|
FAN
54
Financial Advisors Network
Tustin,
California
| – | -$201K | -1,750 | Closed |
|
55
Osaic Holdings
Scottsdale,
Arizona
| – | -$81K | -705 | Closed |
|
BSX.PRA Hedge Fund Activity: Q1 2022 in Review
44 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q1 2022, worth a combined $1.11B — up 0.92% from $1.1B a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BSX.PRA and 6 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.
The largest buyer was Allianz Asset Management, adding an estimated $31.2M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $17.2M sold.
- 44 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q1 2022, down from 47 in Q4 2021.
- Funds reported $1.11B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q1 2022, up 0.92% quarter-over-quarter.
- 6 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q1 2022 and 9 closed out, a net change of -3 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q1 2022 was Allianz Asset Management, an estimated $31.2M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q1 2022 was Janus Henderson Group, an estimated $17.2M sold.
Based on aggregated 13F filings for Q1 2022.